Imaging May Spare Nerves in Prostate Cancer Surgery

This article originally appeared here.
Imaging May Spare Nerves in Prostate Cancer Surgery
Imaging May Spare Nerves in Prostate Cancer Surgery

WEDNESDAY, Jan. 25 (HealthDay News) -- The use of preoperative magnetic resonance imaging (MRI) can help guide surgical decisions that may spare nerves in men with prostate cancer undergoing robotic-assisted laparoscopic prostatectomy (RALP), according to a study published online Jan. 24 in Radiology.

Timothy D. McClure, M.D., from the University of California Los Angeles, and colleagues examined whether preoperative prostate MRI influenced the decision to preserve neurovascular bundles and the extent of surgical margins in 104 men with biopsy-proven prostate cancer who underwent RALP. One surgeon planned surgery before and after review of the MRI report, and the differences were determined and compared with the actual surgical and pathological results.

The researchers found that review of preoperative MRI results led to changes in the surgical plan in 27 percent of patients (28 men). The plan was modified to a nerve-sparing technique in 61 percent of these cases and to a non-nerve-sparing technique in the remaining 39 percent of cases. Surgical margins were positive in 6.7 percent of the 104 patients (seven men). There were no positive margins on the side of the prostate in patients whose surgical plan was changed to a nerve-sparing technique.

"To our knowledge, this is the first report demonstrating the value of MRI in planning RALP," the authors write. "On the basis of our initial experience, prostate MRI may be useful for helping surgeons plan the extent and side of nerve sparing during RALP."

Several authors disclosed financial relationships with Siemens Medical Systems and one author disclosed a financial tie to MedQIA.

Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs